(MDLZ) Mondelez International - Overview
Sector: Consumer Defensive | Industry: Confectioners | Exchange: NASDAQ (USA) | Market Cap: 77.584m USD | Total Return: -2.6% in 12m
Avg Turnover: 410M
EPS Trend: -56.0%
Qual. Beats: 1
Rev. Trend: 93.9%
Qual. Beats: 2
Warnings
Fakeout
Tailwinds
Garp
Mondelez International, Inc. (MDLZ) is a global manufacturer and marketer of snack foods and beverages, operating across North America, Europe, Latin America, Asia, the Middle East, and Africa. Its product portfolio is centered on biscuits, baked snacks, and chocolate, featuring major global brands such as Oreo, Cadbury, and Toblerone. The company utilizes a multi-channel distribution strategy involving direct store delivery, wholesalers, and e-commerce platforms.
Operating within the Packaged Foods & Meats sub-industry, Mondelez focuses on high-margin snacking categories which typically exhibit lower price elasticity compared to general grocery staples. The business model relies heavily on brand equity and global supply chain scale to maintain market share across diverse retail environments, ranging from club stores to convenience stations. For a deeper look into these financial trends, you can explore the data on ValueRay.
Formerly known as Kraft Foods Inc., the company rebranded in 2012 to focus specifically on its international snacking operations. Headquartered in Chicago, Mondelez maintains a diverse revenue stream by balancing mature Western markets with expansion into emerging economies.
- Volatile cocoa and sugar prices impact gross margins and product pricing strategies
- Emerging market demand growth offsets volume stagnation in mature Western economies
- Strategic acquisitions in high-growth snack categories drive incremental revenue expansion
- Input cost inflation and supply chain disruptions pressure short-term operating profitability
- Shifting consumer preferences toward healthy snacking options necessitate continuous product portfolio innovation
| Net Income: 2.61b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.04 > 0.02 and ΔFCF/TA -1.19 > 1.0 |
| NWC/Revenue: -27.37% < 20% (prev -22.69%; Δ -4.68% < -1%) |
| CFO/TA 0.05 > 3% & CFO 3.89b > Net Income 2.61b |
| Net Debt (20.7b) to EBITDA (5.08b): 4.07 < 3 |
| Current Ratio: 0.54 > 1.5 & < 3 |
| Outstanding Shares: last quarter (1.29b) vs 12m ago -1.00% < -2% |
| Gross Margin: 28.77% > 18% (prev 0.33%; Δ 2.84k% > 0.5%) |
| Asset Turnover: 56.13% > 50% (prev 52.90%; Δ 3.23% > 0%) |
| Interest Coverage Ratio: 9.87 > 6 (EBITDA TTM 5.08b / Interest Expense TTM 375.0m) |
| A: -0.15 (Total Current Assets 12.7b - Total Current Liabilities 23.5b) / Total Assets 71.1b |
| B: 0.51 (Retained Earnings 36.3b / Total Assets 71.1b) |
| C: 0.05 (EBIT TTM 3.70b / Avg Total Assets 70.0b) |
| D: 0.55 (Book Value of Equity 24.9b / Total Liabilities 45.3b) |
| Altman-Z'' = 1.61 = BB |
| DSRI: 0.95 (Receivables 5.38b/5.26b, Revenue 39.3b/36.5b) |
| GMI: 1.14 (GM 28.77% / 32.74%) |
| AQI: 1.00 (AQ_t 0.66 / AQ_t-1 0.66) |
| SGI: 1.08 (Revenue 39.3b / 36.5b) |
| TATA: -0.02 (NI 2.61b - CFO 3.89b) / TA 71.1b) |
| Beneish M = -2.91 (Cap -4..+1) = A |
As of May 24, 2026, the stock is trading at USD 61.50 with a total of 5,217,318 shares traded.
Over the past week, the price has changed by +2.18%,
over one month by +10.17%,
over three months by +3.17% and
over the past year by -2.56%.
Mondelez International has received a consensus analysts rating of 4.07. Therefore, it is recommended to buy MDLZ.
- StrongBuy: 11
- Buy: 8
- Hold: 9
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 67.2 | 9.3% |
P/E Forward = 20.3252
P/S = 1.9739
P/B = 3.0683
P/EG = 1.0106
Revenue TTM = 39.3b USD
EBIT TTM = 3.70b USD
EBITDA TTM = 5.08b USD
Long Term Debt = 15.5b USD (from longTermDebt, last quarter)
Short Term Debt = 2.88b USD (from shortTermDebt, last quarter)
Debt = 22.2b USD (from shortLongTermDebtTotal, last quarter) + Leases 598.0m
Net Debt = 20.7b USD (calculated: Debt 22.2b - CCE 1.52b)
Enterprise Value = 98.3b USD (77.6b + Debt 22.2b - CCE 1.52b)
Interest Coverage Ratio = 9.87 (Ebit TTM 3.70b / Interest Expense TTM 375.0m)
EV/FCF = 38.17x (Enterprise Value 98.3b / FCF TTM 2.58b)
FCF Yield = 2.62% (FCF TTM 2.58b / Enterprise Value 98.3b)
FCF Margin = 6.55% (FCF TTM 2.58b / Revenue TTM 39.3b)
Net Margin = 6.65% (Net Income TTM 2.61b / Revenue TTM 39.3b)
Gross Margin = 28.77% ((Revenue TTM 39.3b - Cost of Revenue TTM 28.0b) / Revenue TTM)
Gross Margin QoQ = 27.81% (prev 28.16%)
Tobins Q-Ratio = 1.38 (Enterprise Value 98.3b / Total Assets 71.1b)
Interest Expense / Debt = 1.69% (Interest Expense 375.0m / Debt 22.2b)
Taxrate = 29.42% (228.0m / 775.0m)
NOPAT = 2.61b (EBIT 3.70b * (1 - 29.42%))
Current Ratio = 0.54 (Total Current Assets 12.7b / Total Current Liabilities 23.5b)
Debt / Equity = 0.86 (Debt 22.2b / totalStockholderEquity, last quarter 25.8b)
Debt / EBITDA = 4.07 (Net Debt 20.7b / EBITDA 5.08b)
Debt / FCF = 8.04 (Net Debt 20.7b / FCF TTM 2.58b)
Total Stockholder Equity = 26.0b (last 4 quarters mean from totalStockholderEquity)
RoA = 3.73% (Net Income 2.61b / Total Assets 71.1b)
RoE = 10.05% (Net Income TTM 2.61b / Total Stockholder Equity 26.0b)
RoCE = 8.93% (EBIT 3.70b / Capital Employed (Equity 26.0b + L.T.Debt 15.5b))
RoIC = 5.33% (NOPAT 2.61b / Invested Capital 49.0b)
WACC = 4.81% (E(77.6b)/V(99.8b) * Re(5.85%) + D(22.2b)/V(99.8b) * Rd(1.69%) * (1-Tc(0.29)))
Discount Rate = 5.85% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -94.39 | Cagr: -2.38%
[DCF] Terminal Value 73.10% ; FCFF base≈2.87b ; Y1≈2.52b ; Y5≈2.03b
[DCF] Fair Price = 9.31 (EV 32.6b - Net Debt 20.7b = Equity 11.9b / Shares 1.28b; r=8.35% [WACC [floored]]; 5y FCF grow -15.0% → 2.50% )
EPS Correlation: -55.97 | EPS CAGR: -4.81% | SUE: 1.24 | # QB: 1
Revenue Correlation: 93.93 | Revenue CAGR: 4.00% | SUE: 2.77 | # QB: 2
EPS current Quarter (2026-06-30): EPS=0.68 | Chg30d=-1.84% | Revisions=-53% | Analysts=18
EPS next Quarter (2026-09-30): EPS=0.83 | Chg30d=-3.45% | Revisions=-33% | Analysts=18
EPS current Year (2026-12-31): EPS=3.06 | Chg30d=+0.82% | Revisions=+67% | GrowthEPS=+4.7% | GrowthRev=+3.6%
EPS next Year (2027-12-31): EPS=3.39 | Chg30d=+0.61% | Revisions=+57% | GrowthEPS=+10.9% | GrowthRev=+3.0%
[Analyst] Revisions Ratio: +67%